Leverage reference drugs with similar pharmacology, construct PBPK model to extrapolate human PK from preclinical animal data, predict minimal effective dose and maximum tolerated dose for First-in-Human trials.
B²O Pharma is an innovative pharmaceutical R&D enterprise focusing on AI-driven clinical pharmacology and quantitative pharmacology, dedicated to advancing model-informed drug development.